WDB Holdings (2475) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
20 Jul, 2026Executive summary
Revenue for 1Q FY2025 increased by 3.4% year-over-year to ¥12.89 billion, driven by strong CRO segment performance.
Operating profit rose 2.5% year-over-year to ¥1.32 billion, and ordinary profit increased 1.8%, while net profit declined 11.9% to ¥550–551 million due to temporary corporate tax effects.
Staff compensation was raised by 5.6% in April as part of a mid- to long-term management plan, impacting margins.
Human resources business consolidated support desk operations to improve efficiency.
CRO business, especially WDB Coco and Medfiles, focused on high-margin operations and saw strong performance.
Financial highlights
1Q FY2025 revenue: ¥12.89 billion, up 3.4% year-over-year; operating profit: ¥1.32 billion (up 2.5%); ordinary profit: ¥1.32 billion (up 1.8%).
Net profit: ¥550–551 million, down 11.9% year-over-year due to one-time tax impact.
Gross profit margin slightly decreased to 23.3% (from 23.7% previous year); operating margin: 10.2%; ordinary margin: 10.3%.
Comprehensive income for the quarter was ¥660 million, down 6.0% year-over-year.
EPS for the quarter was ¥28.11, compared to ¥31.89 in the prior year.
Outlook and guidance
Full-year FY2025 revenue forecast: ¥51.8 billion, up 5.1% year-over-year.
Operating profit is projected to decline 13.1% year-over-year to ¥4,750 million; net income forecast is ¥2,970 million, down 16.3%.
Dividend payout ratio target remains at 40%, but dividend per share is expected to decrease temporarily; annual dividend forecast is ¥72.50 per share.
Latest events from WDB Holdings
- Revenue up 4.0% YoY, but profits fell due to higher staff costs; CRO segment outperformed.2475
Q2 202520 Jul 2026 - Revenue up 4.2% YoY, but profit declined on higher staff costs; outlook unchanged.2475
Q3 202520 Jul 2026 - Revenue up 3.7% YoY, but profits fell on higher costs; FY2026 outlook cautious.2475
Q4 202520 Jul 2026 - Net profit rose on lower taxes despite softer revenue and profit, with a share buyback announced.2475
Q2 202620 Jul 2026 - Net profit jumped 55.9% on stable revenue, led by staffing growth and CRO weakness.2475
Q1 202620 Jul 2026 - Profit and revenue fell, but staffing grew and modest recovery is forecast for FY2027.2475
Q4 202620 Jul 2026 - Revenue and profit fell as CRO segment weakened, but staffing stayed resilient; outlook steady.2475
Q3 202620 Jul 2026